Related Articles

• Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia
• α‑spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model
• Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway
• Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis
• Inhibitory effect of rape pollen supercritical CO2 fluid extract against testosterone‑induced benign prostatic hyperplasia in rats